At present, several new staging systems combining the AJCC with other biomarkers including carcinoembryonic antigen levels, pathological N stage, and the prognostic score for evaluating the prognosis of CRC patients were established (12–14). The gene discussed is CEACAM5; the disease is colorectal carcinoma.